CSL Ltd.

Founded in 1916, CSL Ltd. is a global biotech leader with 3 segments—CSL Behring (plasma & gene therapies), CSL Seqirus (influenza & pandemic solutions), CSL Vifor (iron‑deficiency & nephrology). It markets across 7+ countries, generating IP royalties and sustaining growth.

Headquarters: Australia (AUS)

CSL Ltd. Logo
Company Profile
  • Employees: 29,904
  • HQ: Melbourne
Traded Instruments
+ Add Instrument 1
Symbol Name Type Exchange Currency ISIN Status Actions
CSL CSL Ltd.
Cap: 87.1B | P/E: 19.7
EQUITY ASX AUD AU000000CSL8 Active
📈
Home Login